Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04093167
Title Study of Molecular Response Adaptive Immuno-Chemotherapy in Patients With NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

lung non-squamous non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST